Featured Research

from universities, journals, and other organizations

How 'beige' fat makes the pounds melt away

Date:
August 28, 2012
Source:
Universität Bonn
Summary:
Researchers have decoded a signal path that could boost the burning of body fat. Mice that are missing a signal switch called VASP are clearly leaner and have more of the coveted brown and beige-colored fat cells that convert energy into heat. This might point the way to a new method for fighting obesity.

Researchers from the University of Bonn and the Max Planck Institute of Biochemistry in Martinsried have decoded a signal path that could boost the burning of body fat. Mice that are missing a signal switch called VASP are clearly leaner and have more of the coveted brown and beige-colored fat cells that convert energy into heat. This might point the way to a new method for fighting obesity.

The researchers presented their results in the current issue of the journal Science Signaling.

The numbers of obese people are climbing steeply all over the world-with obvious major consequences for their health. Due to excess food intake and a lack of physical activity, but also due to genetic factors, the risk for overweight people dying from diseases like coronary heart disease, diabetes and atherosclerosis increases. "The body's fat reserves are actually used as a place to store energy that allows surviving lean times," says Prof. Dr. Alexander Pfeifer, Director of the Institute of Pharmacology and Toxicology of the University of Bonn. "But nowadays, hardly anyone in the industrialized nations is exposed to such hunger phases anymore."

A signal path boosts the burning of fat in the body

Since many people ingest more energy in their diet than they can burn, many harbor dreams of a magic pill that will simply make fat melt away. Now, scientists working with Prof. Pfeifer in collaboration with colleagues from Epileptology and from the PharmaCenter Bonn, together with the Max Planck Institute of Biochemistry in Martinsried -- have discovered a signal path in the metabolism of mice that is indeed able to greatly boost combustion inside the rodents' bodies.

"Science distinguishes between three different types of fat," reports Prof. Pfeifer. White fat is used to store energy and is found in the "problem zones" of overweight people. "Brown fat cells, however, are used as a kind of heating unit," says the pharmacologist. "In babies, they make sure that they do not lose too much heat." Unfortunately, adults have hardly any brown fat cells left-except for small areas at the back of their necks and along their spines. The third category-the so-called "beige fat cells"-are the ones the researchers are betting on. "Just like brown fat cells, they are efficient at converting energy from food into heat, and they can form from the undesirable white fat cells," explains Prof. Pfeifer.

How can white fat cells be converted into brown or beige ones?

Consequently, the team's research focused on how to turn the white fat cells into as many beige ones as possible. "The issue was finding a way to brown white fat -- of course, not in a skillet, but directly inside the body," the University of Bonn pharmacologist summarized the problem. In a study published in 2009, the team around Prof. Pfeifer found that brown fat needs the neurotransmitter "cGMP." And according to the new findings, this is also true for beige fat. The researchers now studied in mice where cGMP comes from and how it is regulated.

These studies showed that vasodilator-stimulated phosphoprotein (VASP) plays an essential role as a switch on a signal path that slows down the formation of brown and beige fat cells. "This is why mice in which the gene for forming VASP was switched off have the more active brown and beige fat," Prof. Pfeifer summarizes the study results. "These animals are lean and dissipate more energy." In developing a regulator for the VASP/cGMP signaling pathway, the researchers see a potential starting point for promoting the energy- and fat-burning brown fat cells.

Hope for new obesity therapies

"This might even allow us to talk the white fat cells into converting to brown or beige fat," says the University of Bonn researcher. "This might lead to a useful option for successfully treating obesity." But this is still a long way off. So far, this signal path has been described in mice only. "We will have to see first if this is also successful in humans," says Prof. Pfeifer, and added that this was just basic research that could open up new possibilities.


Story Source:

The above story is based on materials provided by Universität Bonn. Note: Materials may be edited for content and length.


Journal Reference:

  1. Alexander Pfeifer et al. A VASP/Rac/sGC pathway controls cGMP production in adipocytes. Science Signaling, 2012 DOI: 10.1126/scisignal.2002867

Cite This Page:

Universität Bonn. "How 'beige' fat makes the pounds melt away." ScienceDaily. ScienceDaily, 28 August 2012. <www.sciencedaily.com/releases/2012/08/120828073053.htm>.
Universität Bonn. (2012, August 28). How 'beige' fat makes the pounds melt away. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2012/08/120828073053.htm
Universität Bonn. "How 'beige' fat makes the pounds melt away." ScienceDaily. www.sciencedaily.com/releases/2012/08/120828073053.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) — New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) — Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) — Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) — Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins